Screener

Income (Loss) from Equity Method Investments

Name: BridgeBio Pharma Income (Loss) from Equity Method Investments by Business Segments
Creator: OpenCapital
License: https://www.opencapital.sh/terms

BridgeBio Pharma·Business Segments·1 segment·Rolls up to Equity Method Income

Breakdown

Segment	Q3 '25	Q4 '25	Q1 '26
Business Segments	-$15.83M	-$21.03M	-$18.28M
Total	-$15.83M	-$21.03M	-$18.28M

Segments

Business SegmentsView metric